| 1 |
Lee RC, Feinbaum RL, Ambros V. The C. Elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J]. Cell, 1993,75(5):843-854.
|
| 2 |
Yeung ML, Bennasser Y, LE SY, et al. siRNA, miRNA and HIV: promises and challenges[J]. Cell Res, 2005,15(11-12):935-946.
|
| 3 |
Kim VN. Small RNAs: classification, biogenesis, and function[J]. Mol Cells, 2005,19(1):1-15.
|
| 4 |
Houzet L, Yeung ML, de Lame V, et al. MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals[J]. Retrovirology, 2008, 5:118.
|
| 5 |
Ahluwalia JK, Khan SZ, Soni K, et al. Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication[J]. Retrovirology, 2008,5:117.
|
| 6 |
Nathans R, Chu CY, Serquina AK, et al. Cellular microRNA and P bodies modulate host-HIV-1 interactions[J]. Mol Cell, 2009,34(6):696-709.
|
| 7 |
Frattari G, Aagaard L, Denton PW. The role of miR-29a in HIV-1 replication and latency[J]. J Virus Erad, 2017,3(4):185-191.
|
| 8 |
王宇歌. HIV-1感染者血浆miRNA分布变化研究[D]. 北京：北京协和医学院, 2012.
|
| 9 |
Swaminathan G, Rossi F, Sierra LJ, et al. A role for microRNA-155 modulation in the anti-HIV-1 effects of Toll-like receptor 3 stimulation in macrophages[J]. PLoS Pathog, 2012,8(9):e1002937.
|
| 10 |
Ruelas DS, Greene WC. An integrated overview of HIV-1 latency[J]. Cell, 2013,155(3):519-529.
|
| 11 |
Sung TL, Rice AP. miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1[J]. PLoS Pathog, 2009,5(1):e1000263.
|
| 12 |
Triboulet R, Mari B, Lin YL, et al. Suppression of microRNA-silencing pathway by HIV-1 during virus replication[J]. Science, 2007,315(5818):1579-1582.
|
| 13 |
Lodge R, Ferreira Barbosa JA, Lombard-Vadnais F, et al. Host MicroRNAs-221 and -222 Inhibit HIV-1 Entry in Macrophages by Targeting the CD4 Viral Receptor[J]. Cell Rep, 2017,21(1):141-153.
|
| 14 |
Zhang HS, Chen XY, Wu TC, et al. MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFκB pathway[J]. FEBS Lett, 2012,586(23):4203-4207.
|
| 15 |
Zhang HS, Wu TC, Sang WW, et al. MiR-217 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation by down-regulation of SIRT1[J]. Biochim Biophys Acta, 2012,1823(5):1017-1023.
|
| 16 |
Huang JL, Wang FX, Argyris E, et al. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4＋T lymphocytes[J]. Nat Med, 2007,13(10):1241-1247.
|
| 17 |
Patel P, Ansari MY, Bapat S, et al. The microRNA miR-29a is associated with human immunodeficiency virus latency[J]. Retrovirology, 2014,11:108.
|
| 18 |
Ruelas DS, Chan JK, Oh E, et al. MicroRNA-155 reinforces HIV latency[J]. J Biol Chem, 2015,290(22):13736-13748.
|
| 19 |
Wang PF, Qu XY, Zhou X, et al. Two cellular microRNAs, miR-196b and miR-1290, contribute to HIV-1 latency[J]. Virology, 2015,486:228-238.
|
| 20 |
Cheng K, Rai P, Plagov A, et al. MicroRNAs in HIV-associated nephropathy (HIVAN)[J]. Exp Mol Pathol, 2013,94(1):65-72.
|
| 21 |
Cheng K, Rai P, Plagov A, et al. Rapamycin-induced modulation of miRNA expression is associated with amelioration of HIV-associated nephropathy (HIVAN)[J]. Exp Cell Res, 2013, 319(13):2073-2080.
|
| 22 |
Rai P, Plagov A, Kumar D, et al. Rapamycin-induced modulation of HIV gene transcription attenuates progression of HIVAN[J]. Exp Mol Pathol, 2013,94(1):255-61.
|
| 23 |
Pacifici M, Delbue S, Ferrante P, et al. Cerebrospinal fluid miRNA profile in HIV-encephalitis[J]. J Cell Physiol, 2013,228(5):1070-1075.
|
| 24 |
Mishra R, Singh SK. HIV-1 Tat C modulates expression of miRNA-101 to suppress VE-cadherin in human brain microvascular endothelial cells[J]. J Neurosci, 2013,33(14):5992-6000.
|
| 25 |
Kottilil S, Yan MY, Reitano KN, et al. Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells[J]. Hepatology, 2009,50(1):34-45.
|
| 26 |
Murray DD, Suzuki K, Law M, et al. Circulating miR-122 and miR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individuals[J]. Sci Rep, 2017,7(1):10934.
|
| 27 |
Bandyopadhyay S, Friedman RC, Marquez RT, et al. Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture[J]. J Infect Dis, 2011,203(12):1753-1762.
|
| 28 |
Fulcher JA, Koukos G, Koutsioumpa M, et al. Unique microRNA expression in the colonic mucosa during chronic HIV-1 infection[J]. AIDS, 2017,31(14):1925-1934.
|
| 29 |
Yan Q, Ma XT, Shen CY, et al. Inhibition of Kaposi′s sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258[J]. J Virol, 2014,88(9):4987-5000.
|
| 30 |
张琰琰，高波，段月勋，等. HIV感染相关性弥漫大B细胞淋巴瘤患者组织中miRNA表达谱的初步研究[J]. 中华血液学杂志, 2015,36(4):337-340.
|
| 31 |
Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection[J]. Science, 2010,327(5962):198-201.
|
| 32 |
Cillo AR, Mellors JW. Which therapeutic strategy will achieve a cure for HIV-1? [J]. Curr Opin Virol, 2016,18:14-19.
|